Current Investments
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
S*BIO Pte Ltd
Jan-Anders Karlsson, Singapore
S*Bio joined our portfolio as a former Chiron investment. S*Bio is a drug discovery company with a small molecule approach to cancer targets.
Sonitus Medical Inc.
Amir Abolfathi CEO, San Mateo CA, US
Sonitus Medical is developing innovative medical device products to treat hearing disorders.
Symetis AG
Jacques Essinger, Lausanne, CH
Development of a catheter-mediated delivery system on the beating heart to insert stented mechanical valves for application in cardiac valve replacement.
SynphaBase AG
Arthur Bodenmueller, Pratteln, CH
SynphaBase offers custom-synthesis of life science intermediate products obtained by synthetic and bioorganic methods, including chiral building blocks, amino and hydroxyl carbonic acids and peptides/glycopeptides.